RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 November 2011 | By Michael Matthews 

  • FDA and CMS Parallel Review Pilot Program
  • Regulatory Science in FDA's Center for Devices and Radiological Health
  • FDA Proposes Amending the Orphan Drug Regulations


© 2022 Regulatory Affairs Professionals Society.